CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 32  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0659
LYS 10.0233
GLU 20.0145
LEU 30.0072
ARG 40.0083
CYS 50.0067
GLN 60.0034
CYS 70.0116
ILE 80.0306
LYS 90.0238
THR 100.0185
TYR 110.0114
SER 120.0109
LYS 130.0151
PRO 140.0179
PHE 150.0294
HIS 160.0346
PRO 170.0235
LYS 180.0314
PHE 190.0092
ILE 200.0118
LYS 210.0066
GLU 220.0111
LEU 230.0095
ARG 240.0088
VAL 250.0090
ILE 260.0060
GLU 270.0087
SER 280.0076
GLY 290.0105
PRO 300.0080
HIS 310.0067
CYS 320.0081
ALA 330.0123
ASN 340.0107
THR 350.0098
GLU 360.0069
ILE 370.0071
ILE 380.0093
VAL 390.0142
LYS 400.0136
LEU 410.0095
SER 420.0119
ASP 430.0141
GLY 440.0141
ARG 450.0203
GLU 460.0179
LEU 470.0159
CYS 480.0077
LEU 490.0100
ASP 500.0174
PRO 510.0204
LYS 520.0435
GLU 530.0388
ASN 540.0491
TRP 550.0062
VAL 560.0053
GLN 570.0206
ARG 580.0351
VAL 590.0192
VAL 600.0081
GLU 610.0225
LYS 620.0163
PHE 630.0185
LEU 640.0219
LYS 650.0222
ARG 660.0254
ALA 670.0319
GLU 680.0206
ASN 690.0659

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.